100% of moneycontrol users recommend buying Wockhardt.
What's your call on Wockhardt today?
Read 73 investor views
|Company Name||Last Price||%
|Dr Reddys Labs||2565.45||0.50||2939.80||1999.40||43,640.58|
|Sep' 13||Jun' 13||Mar' 13||Dec' 12|
|Scheme||No. of Shares|
|HDFC Equity Fund (G)||1,504,285|
|HDFC Mid-Cap Opportunities Fund (G)||224,537|
|HDFC Prudence Fund (G)||164,060|
|ICICI Prudential Exports and Other Services Fund (G)||117,096|
Wockhardt is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 7,244.65 crore.The company has reported a consolidated sales of Rs 1,236.35 crore and a Net Profit of Rs 305.28 crore for the quarter ended Dec 2013.
The company management includes Habil Khorakiwala - Chairman & Group CEO, Murtaza Khorakiwala - Managing Director, Huzaifa Khorakiwala - Executive Director, R A Shah - Director, Aman Mehta - Director, Shekhar Datta - Director, D S Brar - Director, Sanjaya Baru - Director.
It is listed on the BSE with a BSE Code of 532300 and the NSE with an NSE Code of WOCKPHARMA.
Its Registered office is at Wockhardt Towers, Bandra-Kurla Complex,,Bandra (East) Mumbai,Maharashtra - 400051.
Their Registrars are Link Intime India Pvt. Ltd.